Deals & Corporate Governance

  • January 05, 2024

    Former Alexion Exec Avoids Prison In Insider Trading Case

    A Manhattan federal judge sentenced a former Alexion Pharmaceuticals Inc. vice president to eight months of house arrest Friday for tipping off a childhood friend about the company's $1.4 billion purchase of Portola Pharmaceuticals in 2020, rejecting prosecutors' bid for prison time.

  • January 05, 2024

    Opioid Trust Isn't For Care Claims Trader, Trustee Argues

    A healthcare recovery and data company shouldn't be able to transact claims made against an opioid trust in Mallinckrodt's Chapter 11 bankruptcy, a trustee in the case has argued, telling a Delaware federal court that the trust is limited only to insurers and other providers of healthcare benefits.

  • January 05, 2024

    IQVIA Drops Healthcare Ad Deal After Court Pause

    Healthcare data company IQVIA has abandoned its planned purchase of Propel Media after the Federal Trade Commission convinced a court to pause the deal over concerns about the cost of advertising that targets doctors and other healthcare professionals.

  • January 05, 2024

    Healthcare-Focused PE Firm Closes $180M Fund

    Healthcare-focused private equity shop Leavitt Equity Partners, advised by Dorsey & Whitney LLP, on Friday said that it closed its third private equity fund after raising $180 million in commitments.

  • January 05, 2024

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen Lucasfilm use the force in a High Court appeal in a dispute over the use of the late actor Peter Cushing's likeness, defunct crypto lender Celsius bring legal proceedings against cryptocurrency insurance startup Unslashed, and the Kuwaiti pensions authority bring another lawsuit to the table in a $10 million bribery scandal involving the authority’s former boss. Here, Law360 looks at these and other new claims in the U.K.

  • January 04, 2024

    Roche Could Pay $2B In Deal To Develop Potent Cancer Drugs

    Moma Therapeutics announced Thursday that it could receive over $2 billion in milestone payments from Swiss pharmaceutical giant Roche through a new collaboration to develop powerful cancer treatments.

  • January 04, 2024

    Life Sciences Investment Firm TCG Crossover Closes $1B Fund

    TCG Crossover, also known as TCGX, announced Thursday that it has closed a new fund, raising $1 billion in capital to be invested into both private and public companies focused on drug discovery.

  • January 04, 2024

    Hospital Network Told To Provide Contracts In Antitrust Suit

    A Connecticut state judge Thursday ordered Hartford HealthCare Corp. to hand over a raft of contracts with insurers and related documents, some dating back to 2008, as part of a discovery request in a putative class action accusing the hospital network of violating antitrust and unfair trade practices laws.

  • January 04, 2024

    Chancery Rejects Injunction Barring SomaLogic Merger Vote

    Finding that risks to a $1 billion merger outweigh disputed stockholder claims of inadequate disclosures and an unfair process, a Delaware vice chancellor on Thursday refused to block a noon shareholder vote on the tie-up between SomaLogic Inc. and Standard BioTools Inc.

  • January 04, 2024

    Deals Rumor Mill: Cigna, Bain Capital, Amazon

    Cigna is seeking to unload its Medicare Advantage business for up to $4 billion, Bain Capital wants to sell antibodies manufacturer Centrient Pharmaceuticals for $1.1 billion, and Amazon could buy a stake in regional sports networks. Here, Law360 breaks down these and other notable deal rumors from the past week.

  • January 04, 2024

    Medical Tech Co. Buys Breathing Device Biz For Up To $2.5M

    Inspiration Healthcare Group PLC said Thursday that it has bought life support ventilator business Airon Corp. in a deal worth up to $2.5 million, as the British medical technology company eyes entering the "significant strategic market" in the U.S.

  • January 03, 2024

    ACTS Retirement Data Breach Suit Settlement Gets Initial OK

    A Pennsylvania federal judge gave preliminary approval Tuesday to a deal inked by ACTS Retirement Services Inc. to settle claims it failed to protect the personal information of nearly 21,000 people exposed in an April 2022 data breach.

  • January 03, 2024

    5 January Argument Sessions Benefits Attys Should Watch

    The Fifth Circuit will hear arguments this month over whether the Affordable Care Act's anti-discrimination mandate covers sexual orientation and gender identity, and Goldman Sachs workers will seek to revive a class action over proprietary retirement investments.

  • January 03, 2024

    No Fines Over Physician Retirement Offer, HHS OIG Says

    A health system that makes voluntary offers to all physician partners reaching the age of 67 to purchase their partnership units if they stop practicing medicine does not breach the federal Anti-Kickback Statute, the U.S. Department of Health and Human Services said in an advisory opinion posted Wednesday.

  • January 03, 2024

    Chancery Mulls Call To Block $1B SomaLogic Merger

    A Delaware vice chancellor reported plans to rule Thursday morning on a preliminary injunction bid from a proposed class of stockholders targeting the merger of SomaLogic Inc. and Standard BioTools Inc., hours before a noon Eastern time stockholder meeting on the hotly contested biopharmaceutical industry tie-up.

  • January 03, 2024

    Esperion Snags $125M Deal With Daiichi On Cholesterol Drug

    Esperion Therapeutics Inc. on Wednesday announced a $125 million deal with a Japanese pharmaceutical giant to resolve Esperion's demand for $300 million from the company over Esperion's cholesterol reduction drugs.

  • January 03, 2024

    Hartford HealthCare Wants Contracts Left Out Of Antitrust Suit

    Hartford HealthCare Corp. should not have to hand over even more confidential insurer contracts to a putative class of policyholders or be forced to make them public as part of an antitrust suit, counsel for the Connecticut hospital network told a state judge Wednesday.

  • January 03, 2024

    Polsinelli Hires Real Estate Lawyer From Caddis

    BigLaw firm Polsinelli PC has added a shareholder to its real estate and financial services team in Denver who will bring a wealth of experience advising clients both as an in-house attorney and in private practice.

  • January 02, 2024

    Myovant, Sumitomo Beat Investor Suit Over Skadden Advice

    Sumitomo Pharma America Inc. and Myovant Sciences Ltd. have escaped for good a proposed class action alleging the companies' merger was undervalued because the lawyers from Skadden Arps Slate Meagher & Flom LLP who helped negotiate the deal had undisclosed conflicts of interest.

  • January 02, 2024

    Health Service Co., Oncology Firm Kick-Start 2024 IPO Filings

    Private-equity backed healthcare platform BrightSpring Health Services Inc. and bladder-cancer therapy company CG Oncology Inc. filed initial public offering plans on Tuesday, the first companies to join this year's IPO pipeline, under the combined guidance of three law firms.

  • January 02, 2024

    Failed Negotiation Leaves Prisma Hospitals Out Of UHC Network

    Eighteen South Carolina hospitals are now out-of-network providers for UnitedHealthcare customers, the insurer announced Tuesday, saying Prisma Health Facilities caused the change by refusing to budge on its "unsustainable" 20% price hikes during contract negotiations.

  • January 02, 2024

    UK Biopharmaceutical Biz Raises $260M In Series C Funding

    British biopharmaceutical company Apollo Therapeutics revealed Tuesday that it completed a second close of its Series C financing round last month, bringing the total amount raised in the funding round over the course of 2023 to $260 million.

  • January 02, 2024

    Catching Up With Delaware's Chancery Court

    Delaware's busy Court of Chancery barely stopped to take a break at the end of 2023, keeping the courtroom open for hearings on Carvana and Meta, pushing out year-end decisions related to Fox Corp., Oracle and AmerisourceBergen, and making way for new cases involving biomedical venture SomaLogic Inc., U.S. Bancorp, and Capital Square Partners merger target Startek Inc.

  • January 02, 2024

    FTC Wins Pause Of IQVIA Healthcare Ad Deal

    A New York federal court has granted the Federal Trade Commission's request to pause IQVIA's planned purchase of Propel Media for an in-house agency challenge over concerns about competition in the digital healthcare advertising industry.

  • January 02, 2024

    Pa. Court Rejects Red Book Drug Prices For Workers' Comp

    A Pennsylvania appellate court found Tuesday that the Red Book pricing values used by the state's Bureau of Workers' Compensation to determine fair repayment for injured workers' prescription drugs is inconsistent with state law and ordered the agency to find a new way to calculate those costs.

Expert Analysis

  • Time For Law Schools To Rethink Unsung Role Of Adjuncts

    Author Photo

    As law schools prepare for the fall 2023 semester, administrators should reevaluate the role of the underappreciated, indispensable adjunct, and consider 16 concrete actions to improve the adjuncts' teaching experience, overall happiness and feeling of belonging, say T. Markus Funk at Perkins Coie, Andrew Boutros at Dechert and Eugene Volokh at UCLA.

  • Tips For In-House Legal Leaders In A Challenging Economy

    Author Photo

    Amid today's economic and geopolitical uncertainty, in-house legal teams are running lean and facing increased scrutiny and unique issues, but can step up and find innovative ways to manage outcomes and capitalize on good business opportunities, says Tim Parilla at LinkSquares.

  • What Associates Need To Know Before Switching Law Firms

    Excerpt from Practical Guidance
    Author Photo

    The days of staying at the same firm for the duration of one's career are mostly a thing of the past as lateral moves by lawyers are commonplace, but there are several obstacles that associates should consider before making a move, say attorneys at HWG.

  • A Case For Sharing Mediation Statements With Counterparties

    Author Photo

    In light of a potential growing mediation trend of only submitting statements to the mediator, litigants should think critically about the pros and cons of exchanging statements with opposing parties as it could boost the chances of reaching a settlement, says Arthur Eidelhoch at Eidelhoch Mediation.

  • Tackling Long-Tail Legacy Liability Risk: A Defendant's Toolkit

    Author Photo

    Johnson & Johnson was recently rebuffed in its efforts to employ the "Texas Two-Step," which is likely to affect this increasingly popular method to isolate and spin off large asbestos and talc liabilities, but companies have multiple options to reduce long-tail legacy liability risk, says Stephen Hoke at Hoke LLC.

  • Challenging Standing In Antitrust Class Actions: Injury-In-Fact

    Author Photo

    As demonstrated in recent cases, the classic injury-in-fact requirement for Article III standing claimed in most antitrust suits is economic harm — and while concrete harm satisfies the requirement, litigants may still be able to challenge whether economic injury has occurred, say Michael Hamburger and Holly Tao at White & Case.

  • Preparing For Legal Scrutiny Of Data Retention Policies

    Author Photo

    Two recent cases involving Google and Meta should serve as a call to action for companies to ensure their data retention policies are updated and properly implemented to the degree of being able to withstand judicial scrutiny, especially as more data is generated by emerging technologies, say Jack Kallus and Labeed Choudhry at Kaufman Dolowich.

  • Congress Must Reform PBMs To Lower The Cost Of Insulin

    Author Photo

    When the U.S. Senate Committee on Health, Education, Labor and Pensions meets Wednesday to ask why insulin prices are increasing, they should follow the money, and work on curtailing the practices of pharmacy benefit managers that inflate drug prices, says David Balto, a former policy director at the Federal Trade Commission.

  • Attorneys Should Have An Ethical Duty To Advance DEI

    Author Photo

    National and state bar associations are encouraging attorneys to apply diversity, equity and inclusion practices in the legal profession and beyond, and these associations should take it one step further by formally recognizing ethical duties for attorneys to promote DEI, which could better the legal profession and society, says Elena Mitchell at Moore & Van Allen.

  • Data-Driven Insights Are Key To Attracting Today's Clients

    Author Photo

    As law firm growth slows and competition for clients increases, modern firms must rely on robust data analytics to develop the sector-based expertise and industry insights that clients increasingly prioritize in relationships with counsel, says Lavinia Calvert at Intapp.

  • Ghosting In BigLaw: Why Better Feedback Habits Are Needed

    Author Photo

    Not giving assignments or constructive criticism to junior associates can significantly affect their performance and hours, potentially leading them to leave the firm, but partners can prevent this by asking the right questions and creating a culture of feedback, says Rachel Patterson at Orrick.

  • Law Needs A Balance Between Humanism And Formalism

    Author Photo

    A recent Law360 guest article rightly questions the pretextual pseudo-originalism that permits ideology to masquerade as judicial philosophy, but the cure would kill the patient because directness, simplicity and humanness are achievable without renouncing form or sacrificing stare decisis, says Vanessa Kubota at the Arizona Court of Appeals.

  • FTC's Criminal Liaison Unit Enhances Merger Risks

    Author Photo

    As it enters its second year, the Criminal Liaison Unit within the Federal Trade Commission’s Bureau of Competition may streamline and sharpen efforts to detect and refer substantive and procedural violations to prosecutors, increasing the chances of a merger review uncovering potential criminal activity, say attorneys at Norton Rose.